Formation Bio (formerly TrialSpark, rebranded in December 2023) is a New York-based, tech-driven, AI-native pharmaceutical company co-founded by Ben Liu and Linhao Zhang. Rather than discovering molecules, Formation Bio in-licenses and acquires clinical-stage drug assets and runs them through a proprietary, software- and AI-driven development… - View it on GitHub